Data as of Nov 26
| +0.14 / +0.38%|
Grifols SA is a vertically integrated global producer of plasma derivatives. Its activities include sourcing raw material, manufacturing various plasma derivative products and selling and distributing final products to healthcare providers. The company operates through four segments: Bioessence, Hospital, Diagnostic & Raw Materials. The Bioessence segment includes all activities related with products deriving from human plasma for therapeutic use. The Hospital segment comprises of all non-biological pharmaceutical products and medical supplies manufactured by Group companies earmarked for hospital pharmacy. The Diagnostic segment includes the marketing of diagnostic testing equipment, reagents, and other equipment. The Raw Materials segment includes the sale of intermediate biological products and the rendering of manufacturing services to third party companies. The company applies sophisticated science and technology to improve people's health and well-being through providing life-saving products. Grifols was founded by José Antonio Grifols Roig on November 18, 1940 and is headquartered in Barcelona, Spain.
|VÃctor Grifols Roura||Chairman, President & Chief Executive Officer|
|Alfredo Arroyo Guerra||Chief Financial Officer & Vice President|
|Eva Bastida Tubau||VP, Director-Scientific & Medical Affairs|
|Carlos Roura Fernandez||VP & Co-President-Global Industrial Division|
|Montserrat Lloveras Calvo||VP, Director-Corporate Accounting & Reporting|